Today news
The same in other media
02.07 - 22:33
01.07 - 02:43
Supply of opioid antidote naloxone strong during COVID-19
Reading now: 600
The pandemic has been associated with increasing rates of drug overdoses in the United States, with the New York Times relaying an overall increase of 29% in 2020 over the year prior.
Public health professionals point to disrupted healthcare and crisis services, increased drug potency, worsening mental health, and isolation, but what about access to naloxone, a drug that rapidly reverses opioid overdose?
While the available answers aren't as conclusive as one might like, it seems the upstream supply chain—the manufacturing part—hasn't seemed to waver for harm reduction centers.
Even before the pandemic temporarily shut down some substance disorder centers, people who could benefit from naloxone could be stymied by the regulations that vary
The website covid-19.rehab is an aggregator of news from open sources. The source is indicated at the beginning and at the end of the announcement. You can send a complaint on the news if you find it unreliable.
COVID-19
United States
|
Cases: 46 252 513
Deaths: 750 423
Recovered: 0
|
India
|
Cases: 34 321 025
Deaths: 459 652
Recovered: 0
|
Brazil
|
Cases: 21 835 785
Deaths: 608 235
Recovered: 0
|
United Kingdom
|
Cases: 9 215 683
Deaths: 141 607
Recovered: 0
|
Russia
|
Cases: 8 494 589
Deaths: 237 619
Recovered: 0
|